MeiraGTx Holdings (MGTX) Change in Receivables (2020 - 2025)
MeiraGTx Holdings posted quarterly Change in Receivables of $2.5 million for Q4 2025, down 39.25% year-on-year from $4.1 million in Q4 2024, and down 46.67% on a QoQ basis from $4.7 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 6 years of Change in Receivables data on file, last reported at $2.5 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables fell 39.25% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2025 stood at $2.3 million (up 157.63% YoY), and the FY2025 full-year result was $2.3 million, up 157.63% from the prior year.
- Change in Receivables for Q4 2025 stood at $2.5 million, down from $4.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $42.2 million in Q3 2021 and bottomed at -$26.8 million in Q1 2021.
- The 5-year median for Change in Receivables is $1.6 million (2024), against an average of $825368.4.
- Peak annual rise in Change in Receivables reached 1528.67% in 2021, while the deepest fall reached 668.72% in 2021.
- A 5-year view of Change in Receivables shows it stood at -$5.1 million in 2021, then soared by 146.71% to $2.4 million in 2022, then soared by 108.07% to $5.0 million in 2023, then declined by 16.87% to $4.1 million in 2024, then plunged by 39.25% to $2.5 million in 2025.
- The last three Change in Receivables figures came in at $2.5 million (Q4 2025), $4.7 million (Q3 2025), and -$4.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 110.42 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 4.69 Mn |
| Sep 30, 2025 | 4.69 Mn |
| Mar 31, 2025 | -4.85 Mn |
| Mar 31, 2025 | -4.85 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Dec 31, 2024 | 4.12 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | -11.19 Mn |
| Jun 30, 2024 | -11.19 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Dec 31, 2023 | 4.95 Mn |
| Sep 30, 2023 | -10.35 Mn |
| Sep 30, 2023 | -10.35 Mn |
| Jun 30, 2023 | -3.59 Mn |
| Jun 30, 2023 | -3.59 Mn |
| Mar 31, 2023 | 14.14 Mn |
| Mar 31, 2023 | 14.14 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | -12.31 Mn |
| Sep 30, 2022 | -12.31 Mn |
| Jun 30, 2022 | -3.38 Mn |
| Jun 30, 2022 | -3.38 Mn |
| Mar 31, 2022 | 9.17 Mn |
| Mar 31, 2022 | 9.17 Mn |
| Dec 31, 2021 | -5.09 Mn |
| Dec 31, 2021 | -5.09 Mn |
| Sep 30, 2021 | 42.15 Mn |
| Sep 30, 2021 | 42.15 Mn |
| Jun 30, 2021 | 6.10 Mn |
| Jun 30, 2021 | 6.10 Mn |
| Mar 31, 2021 | -26.76 Mn |
| Mar 31, 2021 | -26.76 Mn |
| Dec 31, 2020 | 11.68 Mn |
| Dec 31, 2020 | 11.68 Mn |
| Sep 30, 2020 | 2.59 Mn |
| Sep 30, 2020 | 2.59 Mn |
| Jun 30, 2020 | -3.57 Mn |
| Jun 30, 2020 | -3.57 Mn |
| Mar 31, 2020 | 4.71 Mn |
| Mar 31, 2020 | 4.71 Mn |